Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Patients' willingness to reconsider cancer genetic testing after initially declining: Mention it again

25 Sept 2019

Abstract excerpt

Patients at risk for hereditary cancer syndromes sometimes decline clinically appropriate genetic testing. The purpose of the current study was to understand what preferences, concerns, and desires informed their refusal as well as their current level of interest in being tested. We interviewed patients who had been seen in a hereditary cancer clinic at Vanderbilt University Medical Center and had declined...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Ethics and Legal Issues in Pediatric Healthcare
Share to Genomics and Rare Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31553110
DOI: 10.1002/jgc4.1174

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Patients' willingness to reconsider cancer genetic testing after initially declining: Mention it againPMID 31553110Read ↗

Factors Associated with an Individual's Decision to Withdraw from Genetic Testing for Breast And Ovarian Cancer Susceptibility: Implications for CounselingSemantic proximity Read ↗

Reasons for Declining Preconception Expanded Carrier Screening Using Genome SequencingSemantic proximity Read ↗

Choosing not to undergo predictive genetic testing for hereditary colorectal cancer syndromes: expanding our understanding of decliners and declining.Semantic proximity Read ↗

Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing.Semantic proximity Read ↗

Should pretest genetic counselling be required for patients pursuing genomic sequencing? Results from a survey of participants in a large genomic implementation studySemantic proximity Read ↗

What can we Learn from Patients' Ethical Thinking about the right 'not to know' in Genomics? Lessons from Cancer Genetic Testing for Genetic Counselling.Semantic proximity Read ↗

Identifying Needs: a Qualitative Study of women's Experiences Regarding Rapid Genetic Testing for Hereditary Breast and Ovarian Cancer in the DNA BONus Study.Semantic proximity Read ↗

Concerns About Cancer Risk and Experiences With Genetic Testing in a Diverse Population of Patients With Breast CancerSemantic proximity Read ↗

Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer.Semantic proximity Read ↗

Unraveling non‐participation in genomic research: A complex interplay of barriers, facilitators, and sociocultural factorsSemantic proximity Read ↗

Motivations and concerns of patients considering participation in an implementation study of a hereditary cancer risk assessment program in diverse primary care settings.Semantic proximity Read ↗

Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.